TABLE 7.

ITS results for healthcare expenditures in inpatient setting.

Categories	Coef	95% CI	p
Overall healthcare expenditures
Level change,β2	10,140.00	(1,609.10, 18,670.90)	0.024*
Trend change,β3	−364.40	(-1,194.66, 465.86)	0.394
Durbin-Watson,d	2.00
Drug expenditures
Level change,β2	2,462.74	(-579.45, 5,504.93)	0.119
Trend change,β3	−86.03	(-382.50, 210.44)	0.572
Durbin-Watson,d	1.97
Chemical drug cost
Level change,β2	2,599.54	(236.25, 4,962.83)	0.036*
Trend change,β3	−27.87	(-258.62, 202.88)	0.814
Durbin-Watson,d	1.95
TCM cost
Level change,β2	210.68	(-364.93, 786.29)	0.476
Trend change,β3	−43.52	(-99.66, 12.62)	0.135
Durbin-Watson,d	1.98
Consultation expenditures
Level change,β2	1,490.40	(437.29, 2,543.51)	0.008**
Trend change,β3	−79.86	(-182.56, 22.84)	0.134
Durbin-Watson,d	2.00
Other expenditures
Level change,β2	5,753.79	(2012.48, 9,495.10)	0.004**
Trend change,β3	−72.51	(-438.01, 292.99)	0.700
Durbin-Watson,d	2.00
Out of pocket expenditures
Level change,β2	−45.78	(-2,696.37, 2,604.81)	0.973
Trend change,β3	145.86	(-115.11, 406.83)	0.278
Durbin-Watson,d	1.97
Hospital days
Level change,β2	2.37	(0.61, 4.14)	0.011*
Trend change,β3	0.04	(-0.13, 0.21)	0.675
Durbin-Watson,d	1.99

Abbreviations: Coef., coefficient; SE, standard error; CI, confidence interval.

*p < 0.05, **p < 0.01, ***p < 0.001.